Company: BGLC
Filing Date: 2025-03-31
Form Type: NT 10-K
Source: 0001477932-25-002238
Chunk: 0

Company: BioNexus Gene Lab Corp
Filing Date: 2025-03-31
Form: NT 10-K
Chunk 0
---
<div align='center'>UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 12b-25

Notification Of Late Filing</div>

| ☒ | Form 10-K | ☐ | Form 20-F | ☐ | Form 11-K | ☐ | Form 10-Q | ☐ | Form 10-D | ☐ | Form N-SAR | ☐ | Form N-CSR |

For Period Ended:

<div align='center'>PART I: REGISTRANT INFORMATION</div>

Full Name of Registrant: BioNexus Gene Lab Corp.

Address of Principal Executive Office:

<div align='center'>Unit A-28-7, Tower A, Menara UOA Bangsar,

No. 5 Jln Bangsar Utama 1,

59000 Kuala Lumpur</div>

<div align='center'>PART II: RULES 12b-25(b) AND (c)</div>

If the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b- 25(b), the following should be completed. (Check box if appropriate)

| ☒   | -a                                                                                                                                                                                                                                                                                                                                                                                                                                                                      | The reason described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense |
| (b) | The subject annual report, semi-annual report, transition report on Form 10-K, Form 20-F, Form 11-K, Form N-CEN or Form N-CSR, or portion thereof, will be filed on or before the fifteenth calendar day following the prescribed due date; or the subject quarterly report or transition report on Form 10-Q or subject distribution report on Form 10-D, or portion thereof, will be filed on or before the fifth calendar day following the prescribed due date; and |                                                                                                                                   |
| (c) | The accountant’s statement or other exhibit required by Rule 12b-25(c) has been attached if applicable.                                                                                                                                                                                                                                                                                                                                                                 |                                                                                                                                   |

<div align='center'>PART III: NARRATIVE</div>

The Company has expended a considerable amount of time and effort with its Special Shareholder Meeting in an effort to effect a reverse split of its common stock which has yet to be completed. As a result, the Company’s Form 10-K could not be timely filed without unreasonable effort or expense.

<div align='center'>PART IV: OTHER INFORMATION</div>

|